March 27, 2018

Optimization of a meropenem plus tobramycin combination dosage regimen against hypermutable and non-hypermutable Pseudomonas aeruginosa via mechanism-based modeling and the hollow-fiber infection model.

By fernando | 27 Mar, 18 | 0 Comments |

Landersdorfer CB1,2, Rees VE3,2, Yadav R3, Rogers KE3,2, Kim TH4,…

Evolution of the Pseudomonas aeruginosa aminoglycoside mutational resistome in vitro and in the cystic fibrosis setting.

By fernando | 27 Mar, 18 | 0 Comments |

López-Causapé C1, Rubio R2, Cabot G2, Oliver A2. 1 Servicio…

@arpbigidisba

Retweet on Twitter arpbigidisba Retweeted

Infosalut @infosalut ·

7 Jul

#PublicaSalutIB @microHUSE i @idisbaib ha participat en la publicació d'un estudi sobre l'ús de la ceftazidima-avibactam indueix multiresistència i limita teràpies col·laterals contra P. aeruginosa https://www.infosalut.com/investigacio/estudis-i-projectes/17616 https://doi.org/10.1038/s41467-025-58597-6

@aoliverp73 @sonespases

Reply on Twitter 1942177351510503830 Retweet on Twitter 1942177351510503830 3 Like on Twitter 1942177351510503830 3 X 1942177351510503830

Retweet on Twitter arpbigidisba Retweeted

Docusalut @docusalut ·

1 Jul

Nou article a #Docusalut: 💊🦠 Ceftazidime-avibactam use selects multidrug-resistance and prevents designing collateral sensitivity-based therapies against Pseudomonas aeruginosa http://hdl.handle.net/20.500.13003/24711 @microHUSE @sonespases @idisbaib #PublicaSalutIB

Reply on Twitter 1940040618232738063 Retweet on Twitter 1940040618232738063 3 Like on Twitter 1940040618232738063 2 X 1940040618232738063

arpbigidisba @arpbigidisba ·

2 Jul

The “2nd Hands On Workshop on Pseudomonas aeruginosa Resistance Phenotypes and Whole Genome Sequence Resistome Analysis” will begin in 2 months. This ESCMID workshop is organized by members of our group and will take place at the facilities of the Son Espases University Hospital.

Reply on Twitter 1940426817627918815 Retweet on Twitter 1940426817627918815 3 Like on Twitter 1940426817627918815 4 X 1940426817627918815

Retweet on Twitter arpbigidisba Retweeted

Docusalut @docusalut ·

27 Jun

Nou article a #Docusalut: 🦠 Pseudomonas aeruginosa chronic infections in patients with bronchiectasis: a silent reservoir of carbapenemase-producing epidemic high-risk clones http://hdl.handle.net/20.500.13003/24681 @carla_lc2911 @micro_huse @aoliverp73 #PublicaSalutIB

Reply on Twitter 1938515410179039479 Retweet on Twitter 1938515410179039479 1 Like on Twitter 1938515410179039479 2 X 1938515410179039479

Retweet on Twitter arpbigidisba Retweeted

Docusalut @docusalut ·

27 Jun

Nou pòster a #Docusalut: Caracterización genómica de las enterobacterias productoras de carbapenemasas (EPC) circulantes en las Islas Baleares (2020-2024) http://hdl.handle.net/20.500.13003/24931 @microHUSE @sonespases @sonllatzer @asef_ibsalut @asmen_ibsalut @hmanacor @idisbaib #PublicaSalutIB

Reply on Twitter 1938568440840655256 Retweet on Twitter 1938568440840655256 2 Like on Twitter 1938568440840655256 X 1938568440840655256

arpbigidisba @arpbigidisba ·

27 Jun

Enhorabuena Doctor! Impecable defensa de nuestro compañero Pablo @FraileRibot

Reply on Twitter 1938633201540301287 Retweet on Twitter 1938633201540301287 1 Like on Twitter 1938633201540301287 8 X 1938633201540301287

2nd Hands On Workshop on Pseudomonas Aeruginosa Resistance Phenotypes and Whole Genome Sequence Resistome Analysis

Contact